MichaelJRobertsonMD
Oncology • Indianapolis, INHematologic Oncology
Associate Professor of Medicine, Indiana University
Dr. Robertson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
535 Barnhill Dr
# ROUTE473
Indianapolis, IN 46202Phone+1 317-944-5000Fax+1 317-944-3684
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1987 - 1990
University of ChicagoResidency, Internal Medicine, 1984 - 1987
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1984
Certifications & Licensure
IN State Medical License 1996 - 2025
IL State Medical License 1984 - 2003- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors Start of enrollment: 1997 Oct 01
- Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
Publications & Presentations
PubMed
- 438 citationsPhase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.Michael B. Atkins, Michael J. Robertson, Michael S. Gordon, Michael T. Lotze, Michelle DeCoste
Clinical Cancer Research. 1997-03-01 - 39 citationsCostimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.Michael J. Robertson, Christine Cameron, Susan Lazo, K Cochran, Stephan D. Voss
Natural Immunity. 1996-01-01 - 306 citationsCharacterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.Michael J. Robertson, K Cochran, Christine Cameron, J. M. Le, Ramana Tantravahi
Experimental Hematology. 1996-02-01
Grant Support
- Mechanisms Of STAT4 Deficiency In The Immune System Of Cancer PatientsNational Cancer Institute2007–2011
- Recombinant Human Interleukin-18 For Treatment Of A Patient With MetastaticNational Center For Research Resources2005
- Rhu IL 12 After High Dose &Autologous Hematopoietic Stem CellsNational Center For Research Resources1999–2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
